Compare BHFAN & BRKRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C
Current Price
| Metric | BHFAN | BRKRP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 1400 | 11085 |
| Industry | Life Insurance | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | BHFAN | BRKRP |
|---|---|---|
| Price | $12.50 | $342.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 44.7K | 3.8K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.51 | $256.35 |
| 52 Week High | $17.40 | $419.83 |
| Indicator | BHFAN | BRKRP |
|---|---|---|
| Relative Strength Index (RSI) | 38.28 | 61.33 |
| Support Level | $12.32 | $260.32 |
| Resistance Level | $12.80 | $347.32 |
| Average True Range (ATR) | 0.19 | 4.29 |
| MACD | -0.06 | 0.81 |
| Stochastic Oscillator | 32.29 | 92.09 |
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are: Annuities, that derives majority of the revenue, includes variable, fixed, index-linked, and income annuities; The life segment includes variable, term, universal, and whole life policies; The Run-off segment consists of products that are no longer actively sold and are separately managed, including ULSG, structured settlements, pension risk transfer contracts, certain company-owned life insurance policies and certain funding agreements; and The Corporate & Other segment consists of activities related to funding agreements associated with the company.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.